These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35925120)

  • 41. Don't judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis.
    Basel Allaw M; Sinha A; Ghafourian K; Avery R; Weinberg RL; Lomasney JW; Shah SJ; Patel RB
    Eur Heart J Case Rep; 2023 Aug; 7(8):ytad341. PubMed ID: 37681056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyloid Cardiomyopathy in the Emergency Department.
    Baca M; Newberry M
    J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
    Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A
    Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The paramount importance of repeated left ventricular endomyocardial biopsy during the diagnosis of restrictive cardiomyopathy due to AL cardiac amyloidosis.
    Rubiś P; Rudnicka-Sosin L; Jurczyszyn A; Janion M; Podolec P
    Kardiol Pol; 2016; 74(8):796. PubMed ID: 27553348
    [No Abstract]   [Full Text] [Related]  

  • 46. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
    Nojima Y; Ihara M; Kurimoto T; Nanto S
    Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
    Ton VK; Mukherjee M; Judge DP
    Clin Med Insights Cardiol; 2014; 8(Suppl 1):39-44. PubMed ID: 25628512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
    Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
    Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chylous ascites and chylothorax: an unusual manifestation of cardiac amyloidosis.
    Chen JY; Li WT; Hsu CH; Tsai HW; Tsai WC; Tsai LM; Lin LJ
    Intern Med; 2010; 49(16):1763-6. PubMed ID: 20720355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Light chain deposition disease as a rare cause of restrictive cardiomyopathy.
    Koopman P; Van Dorpe J; Maes B; Dujardin K
    Acta Cardiol; 2009 Dec; 64(6):821-4. PubMed ID: 20128164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carpal Tunnel Syndrome in Transthyretin Cardiac Amyloidosis: Implications and Protocol for Diagnosis and Treatment.
    Boyle RP; Sharan J; Schwartz G
    Cureus; 2021 Apr; 13(4):e14546. PubMed ID: 34017661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transthyretin Cardiac Amyloidosis.
    Mankad AK; Shah KB
    Curr Cardiol Rep; 2017 Aug; 19(10):97. PubMed ID: 28840452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Senile cardiac amyloidosis: Clinical manifestations and non-invasive diagnostic approach.
    Varvarousis D; Polytarchou K; Daskalopoulos N; Mantas I
    Hellenic J Cardiol; 2017; 58(1):60-64. PubMed ID: 28163147
    [No Abstract]   [Full Text] [Related]  

  • 58. [Restrictive cardiomyopathy as a manifestation of primary amyloidosis].
    Brychta T; Parenica J; Zatocil T; Manousek J; Tesák M; Schildberger J; Kala P; Semrád B; Brázdil J; Cíhalová M
    Vnitr Lek; 2004 Jan; 50(1):66-71. PubMed ID: 15015232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
    Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
    Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.
    Hassan W; Al-Sergani H; Mourad W; Tabbaa R
    Tex Heart Inst J; 2005; 32(2):178-84. PubMed ID: 16107109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.